The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 2, 2013, Pages 359-364

  Hemmann, Katrin ^a   Sirotina, Margarita ^b   De Rosa, Salvatore ^a   Ehrlich, Joachim R ^a   Fox, Henrik ^a   Weber, Johannes ^b   Moritz, Anton ^a   Zeiher, Andreas M ^a   Hofmann, Ilona ^b   Schächinger, Volker ^c   Doss, Mirko ^a   Sievert, Horst ^b   Fichtlscherer, Stephan ^a   Lehmann, Ralf ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CardioVascular Center Frankfurt   (Germany)

^c KLINIKUM FULDA   (Germany)

Author keywords

Apical; Femoral; Long term outcome; STS score; Transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA RUPTURE; AORTA VALVE REGURGITATION; ARTICLE; FEMALE; FOLLOW UP; HEMORRHAGIC SHOCK; HUMAN; INSTRUMENT VALIDATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PERCUTANEOUS AORTIC VALVE; PEROPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE DYSFUNCTION; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SOCIETY OF THORACIC SURGEONS SCORE; SURGICAL APPROACH; SURGICAL MORTALITY; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

EID: 84880705558     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt132     Document Type: Article

References (18)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a populationbased study. Lancet 2006;368:1005-11.
2. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006;15:312-21.
3. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-57.
4. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eurointervention 2008;4:193-9.
5. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
6. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-8.
7. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
8. Anderson RP. First publications from the society of thoracic surgeons national database. Ann Thorac Surg 1994;57:6-7.
9. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
10. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881-2.
11. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22; discussion 822-13.
12. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H et al. One-year outcomes of cohort 1 in the Edwards Sapien aortic bioprosthesis European outcome (source) registry: The European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation 2011;124:425-33.
13. Lehmann R, Fichtlscherer S, Schachinger V, Held L, Hobler C, Baier G et al. Favorable long-term survival in patients undergoing multivessel-PCI compared to predicted prognosis of CABG estimated by EuroSCORE: Procedural and clinical determinants of long-term outcome. J Interv Cardiol 2009;22:511-9.
14. Lehmann R, Spyridopoulos I, Kremer J, Zeiher AM, Schachinger V, Fichtlscherer S. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome. J Interv Cardiol 2009;22:311-9.
15. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
16. Trepels T, Martens S, Doss M, Fichtlscherer S, Schachinger V. Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 2009;120:e23-4.
17. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the arterial revascularization therapy study (arts) trial. Circulation 2001;104:533-8.
18. Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg 2004;25: 695-700.